Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Singh, S.
Right arrow Articles by Singh, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Singh, S.
Right arrow Articles by Singh, G.
[Cancer Research 63, 2306-2311, May 1, 2003]
© 2003 American Association for Cancer Research


Tumor Biology

Overexpression of Vimentin

Role in the Invasive Phenotype in an Androgen-independent Model of Prostate Cancer1

Sadmeet Singh, Skanda Sadacharan, Scott Su, Arie Belldegrun, Sujata Persad and Gurmit Singh2

Hamilton Regional Cancer Centre, Hamilton, Ontario, L8V 5C2 Canada [S. Si., S. Sa., S. Su, S. P., G. S.], and Department of Urology, University of California Los Angeles, Los Angeles, California 90095 [A. B.]

The androgen-sensitive LNCaP prostate cancer cell line is less invasive than hormone-insensitive lines. CL1, an aggressive, hormone-insensitive LNCaP subline derived by continuous passaging in hormone-depleted medium, was compared with the parental cell line by cDNA microarray analysis. The gene coding for the intermediate filament protein vimentin was found to be highly up-regulated in the CL1 subline. This difference was confirmed by Northern and Western blots and visualized by immunofluorescence microscopy. To assess the contribution of vimentin to the invasive phenotype, LNCaP cells were stably transfected to overexpress vimentin, and the CL1 cells were transfected with vimentin antisense construct. The invasiveness of the transfected cells was tested using an in vitro invasion assay. We were able to demonstrate that decreasing vimentin expression in the constitutively vimentin-expressing CL1 cells led to a significant decrease in their invasiveness but that forcing expression of vimentin in the LNCaP cells did not augment their invasiveness. These findings imply that vimentin expression contributes to the invasive phenotype but cannot confer it alone.




This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Chu, H. Xu, T. J. Ferro, and P. X. Rivera
Poly(ADP-ribose) polymerase-1 regulates vimentin expression in lung cancer cells
Am J Physiol Lung Cell Mol Physiol, November 1, 2007; 293(5): L1127 - L1134.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Welsh, P. T. K. Saunders, and R. M. Sharpe
The Critical Time Window for Androgen-Dependent Development of the Wolffian Duct in the Rat
Endocrinology, July 1, 2007; 148(7): 3185 - 3195.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Jungert, A. Buck, G. v. Wichert, G. Adler, A. Konig, M. Buchholz, T. M. Gress, and V. Ellenrieder
Sp1 Is Required for Transforming Growth Factor-{beta}-Induced Mesenchymal Transition and Migration in Pancreatic Cancer Cells
Cancer Res., February 15, 2007; 67(4): 1563 - 1570.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. R. van Beijnum, R. P. Dings, E. van der Linden, B. M. M. Zwaans, F. C. S. Ramaekers, K. H. Mayo, and A. W. Griffioen
Gene expression of tumor angiogenesis dissected: specific targeting of colon cancer angiogenic vasculature
Blood, October 1, 2006; 108(7): 2339 - 2348.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. A. Rohn, A. Reitz, A. Paschen, X. D. Nguyen, D. Schadendorf, A. B. Vogt, and H. Kropshofer
A Novel Strategy for the Discovery of MHC Class II-Restricted Tumor Antigens: Identification of a Melanotransferrin Helper T-Cell Epitope
Cancer Res., November 1, 2005; 65(21): 10068 - 10078.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
T L Veveris-Lowe, M G Lawrence, R L Collard, L Bui, A C Herington, D L Nicol, and J A Clements
Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells
Endocr. Relat. Cancer, September 1, 2005; 12(3): 631 - 643.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W. K. Kwok, M.-T. Ling, T.-W. Lee, T. C.M. Lau, C. Zhou, X. Zhang, C. W. Chua, K. W. Chan, F. L. Chan, C. Glackin, et al.
Up-Regulation of TWIST in Prostate Cancer and Its Implication as a Therapeutic Target
Cancer Res., June 15, 2005; 65(12): 5153 - 5162.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
J. K Oosterhoff, J A. Grootegoed, and L. J Blok
Expression profiling of androgen-dependent and -independent LNCaP cells: EGF versus androgen signalling
Endocr. Relat. Cancer, March 1, 2005; 12(1): 135 - 148.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y.-P. Lim, C. Y. Wong, L. L. Ooi, B. J. Druker, and R. J. Epstein
Selective Tyrosine Hyperphosphorylation of Cytoskeletal and Stress Proteins in Primary Human Breast Cancers: Implications for Adjuvant Use of Kinase-Inhibitory Drugs
Clin. Cancer Res., June 15, 2004; 10(12): 3980 - 3987.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.